US Patents With Foreign Priority to France Patent: 03 01849
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-001 | Jul 25, 2013 | RX | Yes | No | RE43879 | ⤷ Subscribe | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ||||
| Abbvie | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-002 | Jul 25, 2013 | RX | Yes | No | RE43879 | ⤷ Subscribe | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ||||
| Abbvie | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-003 | Jul 25, 2013 | RX | Yes | No | RE43879 | ⤷ Subscribe | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ||||
| Abbvie | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-004 | Jul 25, 2013 | RX | Yes | Yes | RE43879 | ⤷ Subscribe | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
